Table 1.
Variable | Thoracic Aorta | Abdominal Aorta | References |
---|---|---|---|
Epidemiology | Rare aneurysm site 20% caused by genetic syndromes |
Most common aneurysm site 20% have familial predisposition |
1–11 |
Embryology | Derived from neural crest | Derived from mesoderm | 12–14 |
Structure | Vascular outer media More numerous lamellar units Grows by synthesizing additional lamellar units Greater elastin & collagen content |
Avascular medial layer Fewer lamellar units Grows by increasing lamellar unit thickness Lower elastin & collagen content |
15–17 |
Mechanics | Greater distensibility TAA breaking stress greater than AAA |
Increased stiffness AAA breaking stress lower than TAA Increased tension per lamellar unit |
18–24 |
Atherosclerosis | Low likelihood of lesion progression from fatty streak to atheroma | Site of most severe atherosclerosis High likelihood of lesion progression from fatty streak to atheroma |
25–26 |
Matrix Metalloproteinases (MMPs) | Inconsistent role for MMP-2 MMP-9 produced by synthetically active SMCs and fibroblasts Lack of MMP-9 attenuated aneurysm development |
Early aneurysm growth driven by MMP-2 MMP-9 produced by macrophages MMP-9 proportional to aneurysm diameter Lack of MMP-9 prevented aneurysm development |
27–39 |
Tissue Inhibitors of Metalloproteinases (TIMPs) | No change or decreased TIMP-1 MMP-2/TIMP-2 ratio elevated |
Elevated TIMP-1 MMP-2/TIMP-2 ratio unchanged |
27–41 |
Immune Mediators | Th1 type immune response in infiltrated aneurysms | Evidence of both pro- and anti-inflammatory cytokines | 43–48 |
TGF-β Response | Increased signaling contributes to aneurysm disease | Overexpression attenuated proteolytic state | 49–50 |